Effect of clopidogrel on platelet aggregation and plasma concentration of fibrinogen in subjects with cerebral or coronary atherosclerotic disease

Clinical and Applied Thrombosis/Hemostasis

Volumn 8, Issue 4, 2002, Pages 381-382

  Jagroop, I Anita ^a   Malley, Michelle ^a   Mikhailidis, Dimitri P ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOPIDOGREL; FIBRINOGEN; SEROTONIN; TICLOPIDINE;

BRAIN ATHEROSCLEROSIS; CORONARY ARTERY ATHEROSCLEROSIS; FIBRINOGEN BLOOD LEVEL; HUMAN; LETTER; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; VASCULAR DISEASE;

EID: 0036818771     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960200800411     Document Type: Letter

References (21)

1. Izaguirre-Avila R, De la Pena-Diaz A, Barinagarrementeria-Aldatz F, et al. Effect of clopidogrel on platelet aggregation and plasma concentration of fibrinogen in subjects with cerebral or coronary atherosclerotic disease. Clin Appl Thromb Haemost 2002;8:169.
2. De Maat MP, Arnold AE, van Buuren S, et al. Modulation of plasma fibrinogen levels by ticlopidine in healthy volunteers and patients with stable angina pectoris. Thromb Haemost 1996;76:166.
3. De Maat MP. Effects of diet, and genes on plasma fibrinogen levels. Ann NY Acad Sci 2001;936:509.
4. 2 release: Pathological implications in vascular disease. J Clin Pathol 1985;38:1166.
5. Mikhailidis DP, Barradas MA, Mier A, et al. Platelet function in patients admitted with a diagnosis of myocardial infarction. Angiology 1987;38:36.
6. Mikhailidis DP, Jeremy JY, Barradas MA, et al. The effect of ethanol on vascular prostacydin synthesis, platelet aggregation and platelet thromboxane release. BMJ 1983;287:1495.
7. Umemura K, Ishihara H, Nakashima M. Anti-platelet effects of clopidogrel in rat middle cerebral artery thrombosis model. Thromb Res 1995;80:209.
8. 2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in non-human primates. Circulation 1993;88:2888.
9. Hirata Y, Umemura K, Uematsu T, et al. An experimental myocardial infarction model in the rat and its properties. Jap J Pharmacol 1995;67:51.
10. Dale J, Myhre E, Rootwelt K. Effects of dipyridamole and acetylsalicylic acid on platelet functions in patients with aortic ball-valve prostheses. Am Heart J 1975;89:613.
11. Fuster V, Chesebro JH, Frye RL, et al. Platelet survival and the development of coronary artery disease in the young adult: Effects of cigarette smoking, strong family history and medical therapy. Circulation 1981;63:546.
12. Jagroop IA, Geroulakos G, Matsagas M, et al. The effect of clopidogrel (Plavix) function in patients with peripheral vascular disease - comparison with aspirin. First International symposium on cardiovascular science from bench to bedside, Hong Kong. J Cardiac Surg 2002; in press.
13. Blann AD, Lanza F, Galajda P, et al. Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis - the influence of aspirin and cigarette smoking. Thromb Haemost 2001;86:777.
14. Barradas MA, Stansby G, Hamilton G, et al. Diminished platelet yield and enhanced platelet aggregability in platelet rich plasma of peripheral vascular disease patients. Int Angiol 1994;13:202.
15. Barradas MA, O'Donoghue S, Mikhailidis DP. Measurement of platelet volume using a channelyzer: Assessment of the effect of agonists and antagonists. In Vivo 1992;6:629.
16. Jagroop IA, Clatworthy I, Lewin J, et al. Shape change in human platelets: Measurement with a channelyzer and visualisation by electron microscopy. Platelets 2000;11:28.
17. Jagroop IA, Mikhailidis DP. An investigation of the serotonergic effects of fenfluramine, dexfenfluramine and dexnorfenfluramine using platelets as neuronal models. Platelets 2000;11:156.
18. Jagroop IA, Mikhailidis DP. Effect of endothelin-1 on human platelet shape change: Reversal of activation by naftidrofuryl. Platelets 2000;11:272.
19. 12, play a role in controlling shape change in humans platelets. Platelets 2002; in press.
20. Wilde JI, Retzer M, Siess S, et al. ADP-induced platelet shape change: An investigation of the signaling pathways involved and their dependence on he methods of platelet preparation. Platelets 2000;11:286.
21. Savi P, Pereillo JM, Uzabiaga MF, et al. Identification and biological activity of the active metabolite of clopidogrel. Thromb Haemost 2000;84:891.